6505--Supplemental Radiopharmaceuticals SAVAHCS

This is a combined synopsis/solicitation is unrestricted/full and open for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26224Q0946

The Southern Arizona VA Healthcare System (SAVAHCS) located in Tucson, AZ has a purchase requirement for radiopharmaceuticals called DaTscan and Vizamyl for base plus option four years. See section B.2 Statement of Work for more details.

NOTE: Potential offers must be aware that the items being acquired are procured as Brand Name or Equal. For those items that are or equal , a description of the salient characteristics are outlined below. The FAR Clause 52.211-6 Brand Name or Equal applies to this acquisition. Any items quoted as equal not confirming to the requirements of clause 52.211-6 will be considered non- responsive and not considered for award.

No remanufactures or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM.

PoP

Item #

Description/Part Number*

Qty

UOM

Base

0001

DaTscan (Ioflupane I 123) injection 5mCi

12

EA

Base

0002

Vizamyl (Flutemetamol F18) injection

42

EA

OY1

1001

DaTscan (Ioflupane I 123) injection 5mCi

24

EA

OY1

1002

Vizamyl (Flutemetamol F18) injection

84

EA

OY2

2001

DaTscan (Ioflupane I 123) injection 5mCi

24

EA

OY2

2002

Vizamyl (Flutemetamol F18) injection

84

EA

OY3

3001

DaTscan (Ioflupane I 123) injection 5mCi

24

EA

OY3

3002

Vizamyl (Flutemetamol F18) injection

84

EA

OY4

4001

DaTscan (Ioflupane I 123) injection 5mCi

24

EA

OY4

4002

Vizamyl (Flutemetamol F18) injection

84

EA

The solicitation will be in accordance with FAR Part 12, 13, and 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412, Size Standard 1,300 Employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award.

Key solicitation milestones are: Submit any questions regarding this procurement via email to hestia.sim@va.gov no later than 10am Pacific Local Time Monday, April 8, 2024. No questions will be answered after this date/time unless determined to be in the best interest of the Government as determined by the Contracting Officer. Telephonic questions will not be accepted or returned. RFI responses will be responded to as necessary in amendment format which will be posted to contract opportunities at http://SAM.gov.

Due to time constraints, responses to the solicitation shall be due on Friday, April 12, 2024 at 10:00 Pacific Time. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Correspondence or questions may be directed to Hestia Sim, Contracting Specialist at Hestia.Sim@va.gov with " 36C26224Q0946, Supplemental Radiopharmaceuticals SAVAHCS in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired.